rs1064797344
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_018105.3(THAP1):c.62C>T(p.Ser21Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S21A) has been classified as Uncertain significance.
Frequency
Consequence
NM_018105.3 missense
Scores
Clinical Significance
Conservation
Publications
- torsion dystonia 6Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Laboratory for Molecular Medicine
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| THAP1 | NM_018105.3 | c.62C>T | p.Ser21Phe | missense_variant | Exon 1 of 3 | ENST00000254250.7 | NP_060575.1 | |
| THAP1 | NM_199003.2 | c.62C>T | p.Ser21Phe | missense_variant | Exon 1 of 2 | NP_945354.1 | ||
| LOC124901940 | XR_007060901.1 | n.100G>A | non_coding_transcript_exon_variant | Exon 1 of 2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| THAP1 | ENST00000254250.7 | c.62C>T | p.Ser21Phe | missense_variant | Exon 1 of 3 | 1 | NM_018105.3 | ENSP00000254250.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Torsion dystonia 6 Pathogenic:2
This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 21 of the THAP1 protein (p.Ser21Phe). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of dystonia (PMID: 24976531, 26610312, 33144682; internal data). ClinVar contains an entry for this variant (Variation ID: 425441). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant disrupts the p.Ser21 amino acid residue in THAP1. Other variant(s) that disrupt this residue have been observed in individuals with THAP1-related conditions (PMID: 19345147, 22377579), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
- -
not provided Pathogenic:1
THAP1: PM1, PM2, PM5, PS4:Moderate -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at